HARVARD BIOSCIENCE INC
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
| Item 9B. | Other Information. |
|---|
On* November 23, 2023,James Green, our Chairman, President and Chief Executive Officer, adopted a trading plan intended to satisfy the affirmative defense available under Rule10b5*-1(c) (the “Trading Plan”). The expiration date of the Trading Plan was* February 7, 2025.The total number of shares of our common stock (the “Shares”) to be sold under the Trading Plan was a maximum of 240,000. Mr. Green terminated the Trading Plan on January 21, 2024.*No Shares were sold under the Trading Plan prior to its termination.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.